PATH
Seattle, Washington, United States
Purpose
to generate immunogenicity and safety data on the BBIL rotavirus vaccine, ROTAVAC and ROTAVAC 5C, in one African country, which will support WHO SAGE policy recommendations and country-level decision-making on potential use of these vaccine
Division
Global Health
Date
November 2017
Region Served
GLOBAL
Committed amount
$2,290,225
Grant topic
Enterics, Diagnostics, Genomics & Epidemiology
Duration (months)
34
Grantee location
Seattle, Washington, United States
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.